S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94

Plethora Solutions Share Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Average Volume2.13 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

Receive PLE News and Ratings via Email

Sign-up to receive the latest news and ratings for Plethora Solutions and its competitors with MarketBeat's FREE daily newsletter.

About Plethora Solutions

Plethora Solutions Holdings PLC is focused on the development and commercialization of its principal pharmaceutical product, PSD502. The Company is engaged in the development and commercialization of pharmaceutical treatments for premature ejaculation in the area of men's sexual health. The Company's segments are Plethora Development and Corporate/Unallocated.


See More Headlines

Industry, Sector and Symbol

Electronic Computer Manufacturing
Year Founded

Sales & Book Value

Annual Sales





Next Earnings Date
Not Optionable


Overall MarketRank

0.93 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Plethora Solutions (LON:PLE) Frequently Asked Questions

What stocks does MarketBeat like better than Plethora Solutions?

Wall Street analysts have given Plethora Solutions a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Plethora Solutions wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

What other stocks do shareholders of Plethora Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Plethora Solutions investors own include Hurricane Energy (HUR), Sirius Minerals (SXX), Ithaca Energy (IAE), Lekoil (LEK), Ixia (XXIA), Carrizo Oil & Gas (CRZO), Greene King (GNK), Hurricane Energy (HRCXF), Ithaca Energy (IACAF) and Premaitha Health (NIPT).

What is Plethora Solutions' stock symbol?

Plethora Solutions trades on the London Stock Exchange (LON) under the ticker symbol "PLE."

How do I buy shares of Plethora Solutions?

Shares of PLE and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

How many employees does Plethora Solutions have?

Plethora Solutions employs 147,000 workers across the globe.

What is Plethora Solutions' official website?

The official website for Plethora Solutions is www.plethorasolutions.co.uk.

Where are Plethora Solutions' headquarters?

How can I contact Plethora Solutions?

Plethora Solutions' mailing address is Hampden House Monument Business Park, Warpsgrove Lane, OXFORD, OX44 7RW, United Kingdom. The specialty pharmaceutical company can be reached via phone at +44-20-30775400.

This page was last updated on 10/17/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.